Latest Revenue Growth News

FlexiRoam Limited reports a modest decline in quarterly cash receipts amid rising operating outflows but counters with strategic marketing optimizations and a director-backed loan to sustain growth.

Streamplay Studio has completed its acquisition of North American indie game publisher Noodlecake Studios, marking a pivotal expansion in its gaming portfolio. The company also reported robust regional growth and a strong cash position, setting the stage for ambitious product launches and market penetration.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with imminent UK export approvals and planned European manufacturing.

ReadCloud has delivered a record December quarter for FY25, reporting a 26% increase in cash receipts and signing 59 new schools, setting the stage for robust growth in the VET-in-Schools and eBooks divisions.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

XPON Technologies reports a modest 2% increase in martech revenue and a strong cash position for Q2 FY25, while navigating an 8% decline in annualised recurring revenue amid strategic sales recalibration.

Nuix projects solid growth in Annualised Contract Value and revenue for the first half of FY25, despite elongated procurement timelines and increased contract complexity.

Myer Holdings has completed its strategic acquisition of Just Group, adding five key apparel brands to its portfolio and issuing 890.5 million new shares to Premier Investments.

Sarytogan Graphite Limited has successfully produced premium ductile cast iron using its Micro80C graphite, positioning itself to capture a high-margin segment amid growing domestic demand.

IDT Australia reports a near doubling of quarterly revenue to $5.3 million, driven by explosive growth in its Advanced Therapies segment, with first-half revenue expected to jump 82%.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.

Pureprofile Limited has upgraded its FY25 financial guidance following a robust first half, highlighted by a 22% revenue increase and a 30% surge in Q2, driven by strong international expansion and automation adoption.